Lipid Metabolism–Signaling Crosstalk in Metabolic Disease and Aging: Mechanisms and Therapeutic Targets
Nutrients · 26.11.2025 · 17 (23) · 3699
DOI: 10.3390/nu17233699 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 26.11.2025. Verfasst von Paalki Sethi und 7 weiteren Autor:innen. Beteiligte Einrichtung: GloNeuro, Sector 107, Vishwakarma Road, Noida 201301, India. Hauptthemen laut MEDLINE: Aging, Lipid Metabolism, Metabolic Diseases, Signal Transduction. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lipid metabolism and lipid-derived signaling together ensure cellular and systemic homeostasis. Their dysregulation causes obesity, type 2 diabetes, cardiovascular disease, NAFLD/MASH, and neurodegeneration throughout life. This review integrates central pathways, such as ACC–FASN-mediated de novo lipogenesis, lipid-droplet lipolysis, and mitochondrial and peroxisomal β-oxidation, and their regulation by insulin–PI3K–Akt, glucagon–cAMP–PKA, SREBPs, PPARs, and AMPK. We emphasize the mechanisms by which bioactive lipids like diacylglycerols, ceramides, eicosanoids, and endocannabinoids serve as second messengers linking nutrient state to insulin signaling, inflammation, and stress response; pathologic accumulation of these species enhances insulin resistance and lipotoxicity. Aging disrupts these axes via diminished catecholamine-stimulated lipolysis, defective fatty-acid oxidation, mitochondrial failure, and adipose depot redistribution, facilitating ectopic fat and postprandial dyslipidemia. We suggest a pathway-to-phenotype paradigm that connects lipid species and tissue environment to clinical phenotypes, allowing for mechanism-to-intervention alignment. Therapeutic avenues range from lipid lowering for atherogenic risk to novel agents targeting ACLY, ACC, FASN, CPT1, and nuclear receptors, with precision lifestyle intervention in diet and exercise. Translation is still heterogeneous because of isoform-dependent effects, safety trade-offs, and inconsistent adherence. We prioritize harmonization of lipidomics with multi-omics for stratifying patients, enriching responders, and bridging gaps between mechanistic understanding and clinical outcome, with focus on age-sensitive prevention and treatment for lipid-mediated metabolic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GloNeuro, Sector 107, Vishwakarma Road, Noida 201301, India.
- Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea.
- Symbiosis Centre for Information Technology (SCIT), Symbiosis International (Deemed University), Rajiv Gandhi InfoTech Park, Hinjawadi, Pune 411057, India.
- GL Bajaj Institute of Technology and Management, Greater Noida 201308, India.
- Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, NY 10022, USA.
- Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA.
ORCID-Profile: Paalki Sethi, Awdhesh Kumar Mishra, Shampa Ghosh, Krishna Kumar Singh, Samarth Sharma, Radoslav Stojchevski, Dimiter Avtanski, Jitendra Kumar Sinha
Zitieren
APA
Sethi, P., Mishra, A. K., Ghosh, S., Singh, K. K., Sharma, S., Stojchevski, R., Avtanski, D., & Sinha, J. K. (2025). Lipid Metabolism–Signaling Crosstalk in Metabolic Disease and Aging: Mechanisms and Therapeutic Targets. Nutrients, 17(23), 3699. https://doi.org/10.3390/nu17233699
Vancouver
Sethi P, Mishra AK, Ghosh S, Singh KK, Sharma S, Stojchevski R, et al. Lipid Metabolism–Signaling Crosstalk in Metabolic Disease and Aging: Mechanisms and Therapeutic Targets. Nutrients. 2025;17(23):3699. doi:10.3390/nu17233699
BibTeX
@article{Sethi2025,
author = {Sethi, Paalki and Mishra, Awdhesh Kumar and Ghosh, Shampa and Singh, Krishna Kumar and Sharma, Samarth and Stojchevski, Radoslav and Avtanski, Dimiter and Sinha, Jitendra Kumar},
title = {Lipid Metabolism–Signaling Crosstalk in Metabolic Disease and Aging: Mechanisms and Therapeutic Targets},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {23},
pages = {3699},
doi = {10.3390/nu17233699}
}
EUVIMED